ATA147691A - Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung - Google Patents
Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierungInfo
- Publication number
- ATA147691A ATA147691A AT0147691A AT147691A ATA147691A AT A147691 A ATA147691 A AT A147691A AT 0147691 A AT0147691 A AT 0147691A AT 147691 A AT147691 A AT 147691A AT A147691 A ATA147691 A AT A147691A
- Authority
- AT
- Austria
- Prior art keywords
- stabilization
- pharmaceutical preparations
- ace inhibitor
- inhibitor content
- content
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55723490A | 1990-07-25 | 1990-07-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA147691A true ATA147691A (de) | 1995-06-15 |
AT400519B AT400519B (de) | 1996-01-25 |
Family
ID=24224569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0147691A AT400519B (de) | 1990-07-25 | 1991-07-24 | Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0468929B1 (de) |
JP (1) | JP2502849B2 (de) |
KR (1) | KR100227156B1 (de) |
AT (1) | AT400519B (de) |
AU (1) | AU639354B2 (de) |
CA (1) | CA2047802C (de) |
CH (1) | CH683150A5 (de) |
CZ (1) | CZ280184B6 (de) |
DE (1) | DE4124409B4 (de) |
DK (1) | DK0468929T3 (de) |
ES (1) | ES2061218T3 (de) |
FI (1) | FI98127C (de) |
GB (1) | GB2246296B (de) |
HU (1) | HU222489B1 (de) |
IE (1) | IE66184B1 (de) |
IL (1) | IL98934A (de) |
IT (1) | IT1290797B1 (de) |
LU (1) | LU87980A1 (de) |
MX (1) | MX9100357A (de) |
MY (1) | MY107183A (de) |
NO (1) | NO912872D0 (de) |
NZ (1) | NZ239078A (de) |
PL (1) | PL167712B1 (de) |
PT (1) | PT98417B (de) |
RU (1) | RU2075310C1 (de) |
SA (1) | SA92130106B1 (de) |
SK (1) | SK278563B6 (de) |
TW (1) | TW212757B (de) |
UA (1) | UA26064A1 (de) |
ZA (1) | ZA915861B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0719280B1 (de) * | 1994-07-13 | 1999-11-10 | Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.D. | Verfahren zur herstellung von verbindungen mit ace-hemmender wirkung somit neue verbindungen, die nuetzlich als ausgangstoffe sind sowie zwischenverbindungen beim genannten verfahren |
DE4444051A1 (de) * | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
HU222497B1 (hu) * | 1996-12-18 | 2003-07-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására |
NZ508544A (en) | 1998-06-05 | 2002-10-25 | Warner Lambert Co | Angiotensin converting enzyme inhibitors, such as quinapril, enalapril and indolapril, stabilised with 1-90 wt% magnesium oxide |
KR100483080B1 (ko) * | 2001-09-21 | 2005-04-14 | 한인규 | 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제 |
US6462022B1 (en) † | 2001-09-24 | 2002-10-08 | Astrazeneca Ab | Lisinopril compositions having large-particle DCPD |
ES2283774T3 (es) * | 2002-01-15 | 2007-11-01 | Actavis Group Hf. | Formulaciones de quinapril e inhibidores de la eca relacionados. |
GB2411355B (en) | 2004-02-27 | 2006-02-22 | Niche Generics Ltd | Pharmaceutical composition |
EP1815857A1 (de) | 2006-02-02 | 2007-08-08 | LEK Pharmaceuticals D.D. | Pharmazeutische Zusammensetzung enthaltend Perindopril |
ES2364011B1 (es) | 2009-11-20 | 2013-01-24 | Gp Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares. |
MX2019014201A (es) | 2017-05-31 | 2020-01-23 | Boehringer Ingelheim Int | Composicion farmaceutica y forma de dosificacion farmaceutica que comprenden (e)-4-(2-(aminometil)-3-fluoroaliloxi)-n-ter-butilbenza mida, proceso para su preparacion, metodos de tratamiento y usos de las mismas. |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB895027A (en) * | 1959-08-03 | 1962-04-26 | Bristol Myers Co | Therapeutic tetracycline compositions |
GB1437788A (en) * | 1973-01-31 | 1976-06-03 | Gist Brocades Nv | Therapeutic compositions |
HU173823B (hu) * | 1975-07-25 | 1979-08-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola |
DE3124090A1 (de) * | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
US4442089A (en) * | 1982-07-06 | 1984-04-10 | E. R. Squibb & Sons, Inc. | Method for treating glaucoma with topical or systemic ACE inhibitor compositions |
US4575539A (en) * | 1985-06-03 | 1986-03-11 | E. R. Squibb & Sons, Inc. | Drug delivery systems including novel interpenetrating polymer networks and method |
US4900559A (en) * | 1985-12-12 | 1990-02-13 | Briston-Myers Company | Stabilized enteric coated aspirin granules and process of preparation |
DE3627613A1 (de) * | 1986-08-14 | 1988-02-18 | Merck Patent Gmbh | Pharmazeutische zubereitung |
US4793998A (en) * | 1986-10-20 | 1988-12-27 | Warner-Lambert Company | Stabilized drug compositions |
US4830853A (en) * | 1986-10-20 | 1989-05-16 | Warner-Lambert Company | Drug compositions stabilized against oxidation |
US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
US4808413A (en) * | 1987-04-28 | 1989-02-28 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions in the form of beadlets and method |
JP2603480B2 (ja) * | 1987-08-05 | 1997-04-23 | 住友製薬株式会社 | 安定化されたアンスラサイクリン系製剤 |
AU608891B2 (en) * | 1987-09-24 | 1991-04-18 | Merck & Co., Inc. | Solubility modulated drug delivery device |
US4912096A (en) * | 1989-06-26 | 1990-03-27 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing an ace inhibitor |
-
1991
- 1991-07-16 HU HU9102385A patent/HU222489B1/hu active IP Right Grant
- 1991-07-17 MY MYPI91001288A patent/MY107183A/en unknown
- 1991-07-22 CH CH2185/91A patent/CH683150A5/de not_active IP Right Cessation
- 1991-07-23 NZ NZ239078A patent/NZ239078A/xx not_active IP Right Cessation
- 1991-07-23 PT PT98417A patent/PT98417B/pt not_active IP Right Cessation
- 1991-07-23 JP JP3205603A patent/JP2502849B2/ja not_active Expired - Lifetime
- 1991-07-23 IT IT91RM000554A patent/IT1290797B1/it active IP Right Grant
- 1991-07-23 DE DE4124409A patent/DE4124409B4/de not_active Expired - Lifetime
- 1991-07-23 IL IL9893491A patent/IL98934A/en not_active IP Right Cessation
- 1991-07-23 LU LU87980A patent/LU87980A1/fr unknown
- 1991-07-23 CZ CS912309A patent/CZ280184B6/cs not_active IP Right Cessation
- 1991-07-23 GB GB9115893A patent/GB2246296B/en not_active Expired - Lifetime
- 1991-07-23 SK SK2309-91A patent/SK278563B6/sk not_active IP Right Cessation
- 1991-07-23 DK DK91810591.7T patent/DK0468929T3/da active
- 1991-07-23 ES ES91810591T patent/ES2061218T3/es not_active Expired - Lifetime
- 1991-07-23 EP EP91810591A patent/EP0468929B1/de not_active Expired - Lifetime
- 1991-07-23 AU AU81286/91A patent/AU639354B2/en not_active Expired
- 1991-07-23 NO NO912872A patent/NO912872D0/no unknown
- 1991-07-24 UA UA5001271A patent/UA26064A1/uk unknown
- 1991-07-24 RU SU915001271A patent/RU2075310C1/ru active
- 1991-07-24 MX MX9100357A patent/MX9100357A/es unknown
- 1991-07-24 AT AT0147691A patent/AT400519B/de not_active IP Right Cessation
- 1991-07-24 FI FI913554A patent/FI98127C/fi not_active IP Right Cessation
- 1991-07-24 PL PL91291219A patent/PL167712B1/pl unknown
- 1991-07-24 CA CA002047802A patent/CA2047802C/en not_active Expired - Lifetime
- 1991-07-24 KR KR1019910012692A patent/KR100227156B1/ko not_active IP Right Cessation
- 1991-07-24 IE IE260891A patent/IE66184B1/en not_active IP Right Cessation
- 1991-07-25 ZA ZA915861A patent/ZA915861B/xx unknown
- 1991-08-13 TW TW080106368A patent/TW212757B/zh not_active IP Right Cessation
-
1992
- 1992-09-09 SA SA92130106A patent/SA92130106B1/ar unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR1100824A (pt) | Composto e composição farmacêutica | |
KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
DE69233491D1 (de) | Pharmazeutische Zusammensetzung enthaltend S-Nitrosolipoproteine und deren Verwendung | |
FI953479A0 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
BR1100329A (pt) | Composto e formulação farmacêutica | |
NO943511D0 (no) | Farmasöytiske preparater og anvendelse derav | |
KR950704251A (ko) | 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof) | |
ITMI920408A0 (it) | Derivati benzopiranici e benzotiopiranici | |
EP0498268A3 (en) | 5-oxo-l-proline derivatives and pharmaceutical use thereof | |
BR9200058A (pt) | Composto e composicao farmaceutica | |
EE9600139A (et) | Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks | |
BR9604950A (pt) | Composição farmacêutica contendo n-clorofenil carbamatos n-clorofeniltiocarbamatos e derivados de n-fosfonoglicina para inibir o crescimento de cânceres e vírus em mamíferos | |
ATA147691A (de) | Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung | |
NZ233122A (en) | Synergistic pharmaceutical composition comprising ketanserine and an ace inhibitor | |
DE59407193D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
MX9101035A (es) | Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene | |
DK72594A (da) | Farmaceutisk præparat med analgerisk virkning indeholdende arginin og (S)-Ibuprofen | |
DE4294862T1 (de) | Pharmazeutische Komposition | |
DE69415570D1 (de) | Esculetin Derivate und pharmazeutische Zusammenstellung | |
DE59505714D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
ZA9711129B (en) | New analogues of camptothecin their medical application and the pharmaceutical substances that contain them | |
DK439589A (da) | Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme | |
NO305750B1 (no) | Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene | |
EE9400337A (et) | Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused | |
DE69800970D1 (de) | Pyridinderivate und sie enthaltende pharmazeutische zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
MK07 | Expiry |
Effective date: 20110724 |